E. Steenwijk

Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity

B. Griffiths, J. Tarn, D. Lendrem, 2018, Rheumatology.

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?

S. Kamphuis, M. Versnel, N. Maria, 2018, Arthritis Research & Therapy.

Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3‐Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon‐Positive Primary Sjögren's Syndrome

H. Drexhage, W. Dik, M. Versnel, 2016, Arthritis & rheumatology.

Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell Histiocytosis

V. van Unen, R. Egeler, Susy Santos, 2016, Oncoimmunology.

Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis

L. M. Voortman, C. Hawkins, D. Roelen, 2020, Frontiers in Immunology.

Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome

P. J. van der Spek, H. Drexhage, W. Beumer, 2016, Annals of the rheumatic diseases.

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study

T. van Wezel, C. V. van Noesel, C. Hutter, 2022, Blood advances.